Researchers estimate that more than half a million people in the U.S. have Crohn's disease, and 600,000 to 900,000 people in the U.S. have ulcerative colitis, according to the National Institute of Diabetes and Digestive ...
Dec 5, 2022
0
14
B cells are critical to the proper functioning of the immune system. However, researchers at Karolinska Institutet have shown that they can sometimes do more harm than good, as their numbers greatly increase after bowel damage, ...
Dec 2, 2022
0
377
COVID-19 did not have a long-term impact on the disease course of inflammatory bowel disease (IBD), according to a study published online Nov. 4 in Therapeutic Advances in Gastroenterology.
Nov 18, 2022
0
5
Short sleep duration and daytime napping appear to increase the risk for inflammatory bowel disease (IBD), according to a study published online Nov. 9 in Alimentary Pharmacology & Therapeutics.
Nov 18, 2022
0
12
An international team led by researchers from the Cluster of Excellence PMI has found biomarkers that indicate at the beginning of anti-TNF alpha therapy whether it will be effective.
Nov 14, 2022
0
11
Like elite firefighters headed into the wilderness to combat an uncontrolled blaze, probiotic bacteria do a better job quelling gut inflammation when they're equipped with the best gear.
Nov 11, 2022
0
2054
For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions.
Nov 9, 2022
0
19
People with inflammatory bowel diseases develop inflammation of the intestine that can cause thickening of the gut wall and life-threatening blockage of the intestinal tube. Twenty to 50 percent of people with Crohn's disease ...
Nov 7, 2022
0
552
Inflammatory bowel disease is a risk factor for giving birth preterm even when in apparent disease remission, a University of Gothenburg study shows. If corroborated, the results may eventually affect recommendations for ...
Nov 7, 2022
0
6
Pfizer reported higher quarterly profits Tuesday as it lifted its full-year forecast for coronavirus vaccine sales and predicted COVID-19 would yield billions more in revenues for the forseeable future.
Nov 1, 2022
0
5
